Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
CONCLUSIONS: This cohort study is the first to report the efficacy of belimumab after minimizing the effect of corticosteroids. Belimumab showed efficacy in improving the SELENA-SLEDAI score, anemia, and low C4 in patients who did not receive corticosteroids or received only low doses.PMID:38031366 | DOI:10.3904/kjim.2023.229
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Yeo-Jin Lee Soo Min Ahn Seokchan Hong Ji-Seon Oh Chang-Keun Lee Bin Yoo Yong-Gil Kim Source Type: research
More News: Anemia | Arthritis | Clinical Trials | Corticosteroid Therapy | Electronic Medical Records (EMR) | Internal Medicine | Lupus | Prednisolone | Rheumatology | Study